# DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

> **NCT06347809** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Prostate Carcinoma

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06347809
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-23
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Closed to consolidate enrollment under another related study
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06347809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06347809, "DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06347809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*